Revenue | ₹1.51Cr |
Net Profits | ₹0.04Cr |
Net Profit Margins | 2.65% |
Vivanza Biosciences Ltd’s revenue fell -77.05% since last year same period to ₹1.51Cr in the Q3 2024-2025. On a quarterly growth basis, Vivanza Biosciences Ltd has generated -49.67% fall in its revenue since last 3-months.
Vivanza Biosciences Ltd’s net profit fell -80.95% since last year same period to ₹0.04Cr in the Q3 2024-2025. On a quarterly growth basis, Vivanza Biosciences Ltd has generated 100% jump in its net profits since last 3-months.
Vivanza Biosciences Ltd’s net profit margin fell -17% since last year same period to 2.65% in the Q3 2024-2025. On a quarterly growth basis, Vivanza Biosciences Ltd has generated 297.35% jump in its net profit margins since last 3-months.
The revenue for Vivanza Biosciences Ltd in the Q3 results 2024 was ₹1.51Cr.
The net profit for Vivanza Biosciences Ltd in the Q3 results 2024 was ₹0.04Cr.
The net profit margin for Vivanza Biosciences Ltd in the Q3 results 2024 was 2.65%.
The revenue for Vivanza Biosciences Ltd in the Q3 results 2023 was ₹6.58Cr.
The net profit for Vivanza Biosciences Ltd in the Q3 results 2023 was ₹0.21Cr.
The net profit margin for Vivanza Biosciences Ltd in the Q3 results 2023 was 3.19%.